SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-23-256933
Filing Date
2023-10-16
Accepted
2023-10-16 16:44:27
Documents
1
Effectiveness Date
2023-10-16

Document Format Files

Seq Description Document Type Size
1 15-12G d364372d1512g.htm 15-12G 10037
  Complete submission text file 0001193125-23-256933.txt   11280
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-35238 | Film No.: 231327733
SIC: 2834 Pharmaceutical Preparations